Contact

Canal Lark Home About Services Legal Overview Safety & Evidence Practical Guidance Contact A plain-language legal & safety field note · 2026 Ibogaine Access In Holland: Legal Status Explained The Netherlands does not list ibogaine on the Opium Act schedules. That narrow fact is often mistaken for medical approval, safe access, or permission to market treatment. It is none of those things. Start with the distinction that matters: unscheduled does not mean authorized medicine, risk-free care, or a guaranteed lawful commercial service. Not a permission slip. Not a treatment recommendation. THE SHORT VERSION: The legal status of a psychedelic substance and the safety of an ibogaine treatment are separate questions. Keep them separate. What the legal label does—and does not—settle Ibogaine access in holland: the central point is that ibogaine and its active compounds are not explicitly listed as a controlled substance on List I or List II of the Dutch Opium Act, also called the Opiumwet. That differs from many controlled drugs, but it does not turn ibogaine into an approved addiction treatment or a licensed medicine in the Netherlands. Accounts of the Dutch ibogaine legal position commonly describe an unscheduled substance. The more useful question is what conduct remains regulated: possession, supply, import, export, administration, medical claims, professional liability, consumer protection, and product safety can all matter under Dutch law. Ibogaine is a plant-derived psychoactive substance found in the root bark of Tabernanthe iboga , a shrub associated with historical use in West African indigenous cultures and traditional medicine. For a basic chemical definition, the general ibogaine entry describes it as a psychoactive alkaloid; that description should not be read as evidence of medical approval. The Netherlands is often discussed alongside broader psychedelic substance policy, but Dutch drug laws do not give every compound the same legal status. Medical

Contact

Published channels